Sleep disturbance is rarely thought of as a seasonal condition, yet population-scale prescription data may be one of the most sensitive instruments for detecting how light deprivation shapes human physiology over time. A large retrospective analysis of primary-care prescription records for hypnotics and sedatives — stratified by month, year, and patient sex — reveals that sleep medication use follows a strikingly consistent annual rhythm tied directly to day length, with meaningful differences between men and women.
Prescription rates for sedative-hypnotic drugs reached their nadir between May and August and climbed to seasonal peaks in winter and early spring. Using incidence rate ratios, the study found that increasing daily light exposure was significantly associated with reduced prescribing rates. Men showed an earlier and more pronounced seasonal decline — spanning February through September with IRRs between 0.88 and 0.95 — while women exhibited a more muted pattern concentrated in the summer months (June–August; IRR 0.94–0.97), with a modest uptick in February that may reflect circadian sensitivity around the winter-to-spring transition. Notably, prescription volumes dropped measurably during the COVID-19 pandemic. Clock transitions between standard time and daylight saving time also produced detectable short-term population-level effects on sleep-related prescribing.
This work sits at the intersection of chronobiology and pharmacoepidemiology, reinforcing what experimental light-exposure studies have suggested: that the suprachiasmatic nucleus's response to photoperiod has real downstream consequences for sleep architecture and sedative need. The sex-specific divergence is particularly noteworthy. Estrogen-related modulation of circadian rhythm sensitivity and higher baseline rates of anxiety-adjacent insomnia in women may explain why female prescribing patterns are less responsive to summer light gains. A critical limitation is the ecological design — prescription counts proxy sleep disorder prevalence but cannot confirm diagnoses, adherence, or whether prescriptions are driven by physician habit rather than patient need. Still, the scale of the dataset lends the seasonal signal considerable credibility. For chronomedicine researchers and sleep clinicians, this analysis provides epidemiological grounding for seasonally adaptive treatment protocols.
